APA (7th ed.) Citation

Li, Y., Li, M., Shats, I., Krahn, J. M., Flake, G. P., Umbach, D. M., . . . Li, L. (2019, January). Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma. PLoS ONE.

Chicago Style (17th ed.) Citation

Li, Yuanyuan, Melissa Li, Igor Shats, Juno M. Krahn, Gordon P. Flake, David M. Umbach, Xiaoling Li, and Leping Li. "Glypican 6 Is a Putative Biomarker for Metastatic Progression of Cutaneous Melanoma." PLoS ONE Jan. 2019.

MLA (9th ed.) Citation

Li, Yuanyuan, et al. "Glypican 6 Is a Putative Biomarker for Metastatic Progression of Cutaneous Melanoma." PLoS ONE, Jan. 2019.